Novo Nordisk Rallies, ServiceNow Dips, Sable Rises
On this episode of Stock Movers:- Novo Nordisk (NVO) shares rallied in trading today following the drugmaker getting US approval to sell a pill version of its blockbuster obesity shot Wegovy. Novo will start selling the pill in the US in early January, the company said in a statement Monday. It is approved to help people lose weight or maintain previous weight loss over the long term. The pill is crucial for Novo’s strategy to take on Eli Lilly, which has said its own oral obesity drug could be approved by March. That would give Novo a head start of just a few months. - ServiceNow (NOW)…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.